baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

InspireMD Inc/ US45779A8466 /

2024-09-24 8:25:10 PM	Chg. +0.08	Volume	Bid9:40:22 PM	Ask9:40:22 PM	High	Low
2.80USD	+2.76%	300 Turnover: 852.50	2.75Bid Size: 100	2.79Ask Size: 100	2.87	2.80

GlobeNewswire 08-06 InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08-05 InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment

GlobeNewswire 07-30 InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on T...

GlobeNewswire 07-01 InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million

GlobeNewswire 05-28 InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. In...

GlobeNewswire 05-14 InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 05-07 InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tu...

GlobeNewswire 04-03 InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire 03-26 InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational...

GlobeNewswire 03-06 InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

GlobeNewswire 02-28 InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Busine...

GlobeNewswire 02-12 InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neu...

GlobeNewswire 01-31 InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory...

GlobeNewswire 01-03 InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice Presi...

GlobeNewswire 2023-12-20 InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System

GlobeNewswire 2023-11-27 InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of ...

GlobeNewswire 2023-11-06 InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire 2023-11-02 InspireMD to Participate in Upcoming November Investor Conferences

GlobeNewswire 2023-11-01 InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Devic...

GlobeNewswire 2023-10-30 InspireMD to Report Third Quarter 2023 Financial Results and Provide Corporate Business Update on Mo...

GlobeNewswire 2023-10-12 InspireMD Supports CMS’ Final National Coverage Determination (NCD) Expanding Coverage of Carotid St...

GlobeNewswire 2023-10-03 InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives

GlobeNewswire 2023-08-31 InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exem...

GlobeNewswire 2022-03-16 InspireMD to Host Key Opinion Leader Event on Carotid Artery Disease Management and Stroke Preventio...

GlobeNewswire 2022-03-08 InspireMD Reports Fourth Quarter and Year-End 2021 Financial Results

InspireMD Inc/ US45779A8466 /

If you wish to receive reply to your feedback, please provide your email address.